TOP 30 Innovative drug development in Seattle, Washington

Avaden Bio is a leading health institution located at 1000 2nd Avenue in Seattle, Washington, United States. Our state-of-the-art facility is dedicated to advancing medical research and developing innovative treatments to improve the health and well-being of our patients. Our team of expert scientists, doctors, and researchers are committed to pushing the boundaries of modern medicine to provide cutting-edge solutions for a wide range of health conditions. At Avaden Bio, we strive to make a positive impact on the lives of our patients and the broader healthcare community.

The Institute for Protein Design, located in Seattle, Washington, is a leading university institution dedicated to creating new proteins to address modern challenges in medicine, technology, and sustainability. Inspired by the remarkable capabilities of natural proteins, the institute designs molecules from scratch to unlock new medical treatments and innovative materials. Their work includes developing Protein Therapeutics, Next-Generation Vaccines, Advanced Drug Delivery systems, Biological Devices, Self-Assembling Nanomaterials, Bioactive Peptides, and Algorithm Development. The institute's impact extends beyond the labs, with successful companies launched and groundbreaking protein medicines developed. One of their achievements includes a COVID-19 vaccine approved in the United Kingdom and South Korea. Additionally, their enzyme KumaMax, designed to treat Celiac disease, is being tested by Takeda Pharmaceuticals. The institute also created Foldit, a video game where players have made significant discoveries in protein folding. Whether you are a student, researcher, partner, or supporter, there is a place for you in the protein design revolution at this innovative institution.

The Department of Bioengineering at the University of Washington, located at 3720 15th Avenue Northeast in Seattle, Washington, is a leading institution in cutting-edge research and innovation. Our Orsborn lab has been awarded a prestigious NIH grant to enhance brain-computer interfaces for movement disorders, while our UW-led team has received a $4.2M grant to develop AI-guided brain stimulation methods for treating mental health disorders. Additionally, our researchers are making significant strides in improving brain health through neural stimulation and developing groundbreaking tests for Alzheimer's disease. Valerie Daggett, a renowned UW professor of bioengineering, has been recognized for her exceptional contributions to the field, including the development of a technology ensuring precise drug release over an extended period. Our faculty members, such as Nancy Allbritton, have been elected to prestigious organizations like the National Academy of Engineering, showcasing the caliber of talent within our department.